TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmavizer AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
65
|
131
|
608 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-12
|
-7
|
496 |
| EBITDA |
-13
|
-7
|
496 |
| Total assets |
756
|
910
|
948 |
| Current assets |
437
|
591
|
629 |
| Current liabilities |
80
|
209
|
214 |
| Equity capital |
635
|
645
|
678 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
84.0%
|
70.9%
|
71.5% |
| Turnover per employee |
65
|
131
|
608 |
| Profit as a percentage of turnover |
-18.5%
|
-5.3%
|
81.6% |
| Return on assets (ROA) |
-1.6%
|
-0.8%
|
52.3% |
| Current ratio |
546.2%
|
282.8%
|
293.9% |
| Return on equity (ROE) |
-1.9%
|
-1.1%
|
73.2% |
| Change turnover |
-66
|
-477
|
322 |
| Change turnover % |
-50%
|
-78%
|
113% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.